Investigator Council
Misson
To support The GOG Foundation, Inc. in its quest to transform the standar of care in gynecologic oncology.
- Business Development Subcommittee: To build deeper and broader relationships with pharmaceutical partners.
- Early Phase Clinical Trial Subcommittee: To foster, support, and increase capabilities of sites to perform early phase drug development including first in human, CAR-T, etc.
- Site Engagement/Trial Challenges Subcommittee: To help overcome start-up, regulatory, enrollment challenges, and improve communications between sites, sponsors and the GOG Foundation.
- Patient Advocacy/Clinical Trial Equity Subcommittee: To advocate for our patients, especially those who are underrepresented and to ensure clinical trial enrollment that reflects the incidence in prevalence in the disease in question that is being studied.
- Translational Research Subcommittee: To develop new biomarkers and understand the scientific underpinnings of our investigational products as well as catalyze the development of novel agents.
Leadership
- Kathleen Moore – University of Oklahoma, Stephenson Cancer Center
- Tom Herzog – University of Cincinnati
- R Wendel Naumann (Chair), Levine Cancer Inst, Atrium Health
- Joyce Barlin, Women’s Cancer Care Associates, Albany, NY
- Stephanie Blank, Icahn School of Medicine at Mount Sinai
- Sharyn Lewin, Holy Name Medical Center
- Michael McHale, University of California, San Diego: Moores Cancer Center
- Emily Prendergast, Intermountain Healthcare
- Mark Shahin, Abington Jefferson Hospital
- Krishnansu Tewari, University of California, Irvine
- Premal Thaker (Chair), Washington University School of Medicine
- Rachel Grisham, Memorial Sloan Kettering Cancer Center
- Gottfried E Konecny, University of California Los Angeles
- Robert Morris, Wayne State University School of Medicine
- Richard Penson, MGH / Harvard
- Debra Richardson, Stephenson Cancer Center, University of Oklahoma Health Sciences Center
- Noelle Cloven (Co-Chair, Texas Oncology Fort Worth
- John Hays (Co-Chair), The Ohio State University James Cancer Center
- Charles Anderson, Willamette Valley Cancer Institute
- Michael Bookman, Kaiser Permanente Northern California
- William Bradley, Medical College of Wisconsin
- Linda Duska, University of Virginia
- Melissa Geller, University of Minnesota
- Cara Mathews, Women and Infants’ Hospital of Rhode Island
- Jyoti Mayadev, University of California San Diego
- Robert R Wenham, Moffitt Cancer Center
- Tashanna Myers (Chair), Baystate Medical Center
- Victoria Bae-Jump, University of North Carolina at Chapel Hill
- Destin Black, Trials365, LLC
- Tara Castellano. LSU Health Sciences Center
- Dana Chase, University of California LA
- Sharad Ghamande, Augusta University (GRU)
- Amanda Jackson, University of Cincinnati
- Colleen McCormick, Johns Hopkins University
- Jessica Thomes Pepin, Minnesota Oncology – US oncology
- Katherine Fuh (Co-Chair), University of California, San Francisco
- Anil K. Sood (Co-Chair), MD Anderson Cancer Center
- Sarah Adams, University of New Mexico Comprehensive Cancer Center
- Doris Benbrook, Stephenson Cancer Center, University of Oklahoma Health Sciences Center
- Casey Cosgrove, The Ohio State University Comprehensive Cancer Center
- Oliver Cosgrove, Stanford University
- Jae-Hoon Kim, Korean Gynecologic Oncology Group (KGOG)
- Panagiotis Konstantinopoulos, Dana Farber Cancer Institute
- Helen Mackay, Sunnybrook Odette Cancer Centre
- Karen McLean, Roswell Park Comprehensive Cancer Center
- Mary Mullen, Washington University School of Medicine
- Andrew Nixon, Duke University
- Fiona Simpkins, University of Pennsylvania
- Oladapo Yeku, Massachusetts General Hospital
- Dmitriy Zamarin, Icahn School of Medicine at Mt. Sinai